President Donald Trump has elevated a rising health policy figure inside his administration, Chris Klomp, to help deliver a series of health-care reforms aimed at lowering costs and improving efficiency across the United States system.

Klomp, a health-care entrepreneur who previously helped lead negotiations with pharmaceutical companies to reduce drug prices, has rapidly emerged as one of the most influential figures within the Department of Health and Human Services.

The president has publicly praised him for his effectiveness, even referring to him as his “favorite Mormon” in recognition of both his faith and his reputation for decisive problem-solving.

In recent weeks Klomp was promoted to chief counselor at the department, giving him broad authority over the agency’s operations.

The position places him in charge of coordinating the work of multiple federal health bodies, including those responsible for public health guidance, drug approvals and the management of major insurance programs.

The department oversees programs that collectively shape a health system serving hundreds of millions of Americans.

The appointment reflects the administration’s determination to deliver tangible health-care achievements ahead of the political season, particularly on issues that resonate strongly with voters such as prescription-drug costs and access to care.

Officials say the president’s wider reform agenda—often described as the “Great Healthcare Plan”—aims to reduce prices, streamline bureaucracy and expand competition within the health market in order to provide relief for American families facing rising medical bills.

Klomp’s reputation inside government circles has been built on a combination of technical expertise and pragmatic management.

Before entering public service, he founded and led health-technology companies focused on improving data sharing between hospitals and insurers.

That background has helped him develop credibility among industry leaders while also giving him experience navigating the complex structures of American health care.

Inside the Department of Health and Human Services, Klomp has begun restructuring internal coordination between agencies and establishing regular strategy meetings among senior officials.

Supporters say the approach is designed to sharpen policy direction and ensure the administration’s priorities—particularly affordability and patient-focused care—are consistently pursued across the federal system.

The administration has also sought to stabilize agencies that have experienced leadership changes in recent months while maintaining momentum behind reforms to major programs such as Medicare.

Klomp continues to oversee the nation’s Medicare program, where he previously gained attention for his hands-on management style and his willingness to work directly with technical teams to resolve operational challenges.

President Trump and senior officials have expressed confidence that the new leadership structure will accelerate progress on lowering drug prices and improving the performance of federal health agencies.

The strategy is expected to play a central role in the administration’s effort to demonstrate concrete health-care gains while pursuing broader reforms aimed at strengthening the country’s medical system and delivering better value for patients.